Financial Focus - Fast Money Recap (7/22/08)
-
Font Size:
Recap of CNBC's Fast Money, Tuesday July 22.
It was a wild day in stocks today, with a “big, strong finish to an otherwise unchanged market,” said host Dylan Ratigan on CNBC's Fast Money on Tuesday.
Karen Finerman said it was still “really short term,” however. Joe Terranova added that “volume was substantial” and that now “everyone is in the financial trades from the long side.” He did, however, caution to “be very careful and get above the lows we saw in March.” Jim Macke also agreed that it was a wild finish, saying that people “made their money in the last hour, making huge gains.”
Pete Najarian said “all the commodity names started getting hit, and when that rotation started, the financials began to take off.” Terranova added that “the energy story isn't over yet.” Finerman warned that we “could still see meaningful trouble ahead.” In describing the current state of the market, Macke said “it's bullish” and wondered how you could see it any other way. He believes the trend “is that clearly financials are long” and hastened to add that he's “out of oil completely and still long financials.” Staying with the talk of financials, Terranova noted that the “trend still looks down and has not reversed yet.” He also says financials will continue to be the story to close out 2008 and into 2009.
Financial Focus: Washington Mutual (WM), E-Trade (ETR)
Focusing on specific companies, Najarian said Washington Mutual had made “a pretty big move right now” and was waiting to see if it would continue. He also liked E-Trade, stating that it was “doing a lot of things right like adding assets and customers.” He acknowledged that “tonight's earnings don't look so good,” but still says that “talking long term, you need to look at WaMu and E-Trade.”
Tech - To Buy or Not to Buy: Apple (AAPL), Yahoo!(YHOO), Microsoft (MSFT)
The analysts then turned to tech, specifically stopping to discuss Apple. Macke said that “nothing fixed Apple's problems,” but Najarian disagreed, saying that you had to “have a look at the big picture.” He felt that “as the iPhone grows, it'll become a bigger piece” and that in the end it would be about the Mac sales.
Focusing more on tech was guest analyst Gene Munster of Piper Jaffray. He recommended buying Yahoo!, saying that it had “investor support to negotiate with Microsoft.” He also felt that “Microsoft needs Yahoo! in order to grow in the next 10 years.” Asked about Apple, Munster said he believes that if it “lowers the price of their products then the Street number will go up and the stock will go up.”
Pharmaceuticals: Pfizer (PFE), Eli Lilly (LLY), Bristol-Myers Squibb (BMY), S&P Biotech (XBI)
Joining the program next was another guest, Lehman Brothers pharmaceutical analyst Tony Butler. “There’s fear around the cholesterol market,” explains Lehman Brothers analyst Tony Butler and that “revenue growth hasn't done well for Pfizer,” despite the fact that it has cut costs. The study revealed that some people who took Vytorin later developed cancer although it wasn't clear if that was merely a coincidence. But coincidence of not, “we wondered if people would just throw their pills away,” Butler says. But they haven't. Does that make Merck a buy on the current dip?
“It’s a value play but I don’t know if Merck stock is going anywhere anytime soon,” replies Butler. “But I have a buy on Schering as a growth story,” he says. Looking ahead, can Pfizer or another drug maker revive the Big Pharma comeback? The key for Pfizer is revenue growth which I don’t think they do well,” replies Butler. They’ve been able to buy back shares but that won’t drive their stock. When asked about upcoming numbers, he was optimistic that “both Eli Lilly and Bristol-Myers Squibb likely have the best numbers.” Butler also advised to “lean toward Bristol over the next two days.” Closing out the segment, Najarian said he'd “love to see either generics or biotechs start jumping,” and Terranova finished by advising to “take a look at the S&P Biotech ticker today.”
Airline Flying Today: JetBlue (JBLU)
Noting that airlines had a huge day of gains, the show welcomed guest JetBlue CEO Dave Barger. Barger said that we were soon “going to see an industry that's much smaller” and commented on JetBlue's planned slowing of growth. Barger said they were planning to “be flat at best into 2009” but was hopeful in saying that “people are going to fly, even if fewer have the opportunity because of airfares moving higher.” He finished the interview by stressing that its plan “is one of organic growth and partnerships with strategic investors.”
Final Trades – Wednesday’s First Moves
Seeking Alpha is not affiliated with CNBC, or Fast Money
Get Seeking Alpha Free Stock Alerts by Email!
Get Free Stock Alerts by Email!
ETFs In Focus
-
Editor's Picks
-
Most Popular
- Report from the Bond War Frontlines
- GDP and the Decline of National Statistics
- Commodities and Emerging Markets: Joined at the Hip?
- On Recent Financial Stories
- Five Good ETF Ideas That Have Yet to Catch On
- Fannie/Freddie Rally: A Product of Fed Intervention
- Full list of Editor's Picks »
- Has Jim Cramer Crossed the Line with Sirius XM? »
- Grab Your Shorts, the Tide Has Turned »
- Looming Financial Catastrophe: A Real Inconvenient Truth »
- Apple's Biggest Rumor: iPod or Jobs? »
- Wall Street Breakfast: Must-Know News »
- Wall Street Breakfast: Must-Know News »
- Wall Street Breakfast: Must-Know News »
- Buffett Takes Berkshire Hathaway on $4 Billion Spending Spree »
- Sirius XM Shorts Scrambling to Cover »
- AIG and the Lunacy of GAAP Reporting »
- Solarfun Power Holdings Co., Ltd. Q2 2008 Earnings Call Transcript »
-
Long Ideas
-
Short Ideas
-
Cramer's Picks
- Natural Gas Is Oversold, and We Are Buying
- Libbey Inc.: The Glass is Half Full
- Mad Money Manual - Cramer's Mad Money (8/28/08)
- An Eye on Gustav - Fast Money Recap (8/28/08)
- Will You Look Back on Today as Your Greatest Missed Opportunity?
- Hedge Fund Manager's Notebook: Why Hummers Are Greener Than Hybrids, and Tech & Homebuilders May Be a Buy
- News Pitch: Why To Buy News Corp
- Is This the Death of Gold & Silver Stocks? Part II
- Pacific Ethanol: Market Growth and Increase in Production to the Rescue
- Office Depot vs. Staples: Discounted Book vs. Superior ROE
- Full list of Long Ideas »
- The Option Arm Triplets: Dead Banks Walking
- Short Thesis Still Intact at FirstFed
- Short Story: Lehman
- 'Buy, But Sell' - What Are Analysts Thinking?
- Nordson's Rally Is Over, For Now - Barron's
- What's So Special About RadioShack? - Barron's
- Salesforce.com: It's All About the Guidance
- Three Casino Stocks Rolling Over
- New Web Site For Short Sellers: You Gotta Love Capitalism
- Commodity Carnage: Where to Turn Next?
- Full list of Short Ideas »
- Mad Money Manual - Cramer's Mad Money (8/28/08)
- Diversified Portfolios - Cramer's Mad Money (8/27/08)
- Gustav Moves Overdone - Cramer's Stop Trading! (8/27/08)
- GrafTech is Too Cheap - Cramer's Stop Trading
- The Rebound List - Cramer's Mad Money (8/26/08)
- The List - Cramer's Stop Trading! (8/26/08)
- Can't Turn My Back - Cramer's Lightning Round (8/26/08)
- The Pelosi Factor - Cramer's Mad Money (8/25/08)
- Buy Tech Weakness - Cramer's Lightning Round (8/25/08)
- Fannie & Freddie Too Difficult - Cramer's Stop Trading! (8/25/08)
- Full list of Cramers Picks »
Trading Center
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »



This article has 4 comments:
Seems like Vytorin's just one glitch in what is overall a solid company.
PFE has a flawless 41-year history of dividend growth and stands to benefit big, along with the entire drug industry as Medicare Part D kicks in over the next few years.
Here's an article by PFE supporter if you're interested in the dividend and management.
www.greenfaucet.com/tr...
Anyone else have any good information about PFE before I jump in?